Ogawa M - Search Results

1

Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.

Ogawa M, Yu WG, Umehara K, Iwasaki M, Wijesuriya R, Tsujimura T, Kubo T, Fujiwara H, Hamaoka T. Ogawa M, et al. Cancer Res. 1998 Jun 1;58(11):2426-32. Cancer Res. 1998. PMID: 9622084

2

Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12.

Ogawa M, Tsutsui T, Zou JP, Mu J, Wijesuriya R, Yu WG, Herrmann S, Kubo T, Fujiwara H, Hamaoka T. Ogawa M, et al. Cancer Res. 1997 Jun 1;57(11):2216-22. Cancer Res. 1997. PMID: 9187124

3

IL-12-induced tumor regression correlates with in situ activity of IFN-gamma produced by tumor-infiltrating cells and its secondary induction of anti-tumor pathways.

Yu WG, Ogawa M, Mu J, Umehara K, Tsujimura T, Fujiwara H, Hamaoka T. Yu WG, et al. Among authors: ogawa m. J Leukoc Biol. 1997 Oct;62(4):450-7. doi: 10.1002/jlb.62.4.450. J Leukoc Biol. 1997. PMID: 9335314

4

B cell-mediated down-regulation of IFN-gamma and IL-12 production induced during anti-tumor immune responses in the tumor-bearing state.

Wijesuriya R, Maruo S, Zou JP, Ogawa M, Umehara K, Yamashita M, Ono S, Fujiwara H, Hamaoka T. Wijesuriya R, et al. Among authors: ogawa m. Int Immunol. 1998 Aug;10(8):1057-65. doi: 10.1093/intimm/10.8.1057. Int Immunol. 1998. PMID: 9723691

5

A critical role for a peritumoral stromal reaction in the induction of T-cell migration responsible for interleukin-12-induced tumor regression.

Ogawa M, Umehara K, Yu WG, Uekusa Y, Nakajima C, Tsujimura T, Kubo T, Fujiwara H, Hamaoka T. Ogawa M, et al. Cancer Res. 1999 Apr 1;59(7):1531-8. Cancer Res. 1999. PMID: 10197625

6

The development of peritumoral stroma required for IL-12 induced tumor regression depends on the T cell/IFN-gamma-involving host-tumor interaction.

Uekusa Y, Ogawa M, Gao P, Iwasaki M, Ono S, Tsujimura T, Nakazawa M, Sakuda M, Clancy B, Fujiwara H, Hamaoka T. Uekusa Y, et al. Among authors: ogawa m. Int J Oncol. 2000 Apr;16(4):805-14. doi: 10.3892/ijo.16.4.805. Int J Oncol. 2000. PMID: 10717251

7

Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12.

Yu WG, Yamamoto N, Takenaka H, Mu J, Tai XG, Zou JP, Ogawa M, Tsutsui T, Wijesuriya R, Yoshida R, Herrmann S, Fujiwara H, Hamaoka T. Yu WG, et al. Among authors: ogawa m. Int Immunol. 1996 Jun;8(6):855-65. doi: 10.1093/intimm/8.6.855. Int Immunol. 1996. PMID: 8671675

8

Administration of IL-12 induces a CD3+ CD4- CD8- B220+ lymphoid population capable of eliciting cytolysis against Fas-positive tumor cells.

Tsutsui T, Mu J, Ogawa M, Yu WG, Suda T, Nagaga S, Saji F, Murata Y, Fujiwara H, Hamaoka T. Tsutsui T, et al. Among authors: ogawa m. J Immunol. 1997 Sep 15;159(6):2599-605. J Immunol. 1997. PMID: 9300678

9

Differential interleukin 12 responsiveness for interferon gamma production in advanced stages of cancer patients correlates with performance status.

Uno K, Setoguchi J, Tanigawa M, Kishi A, Ogawa M, Saotome H, Fujiwara H, Kishida T. Uno K, et al. Among authors: ogawa m. Clin Cancer Res. 1998 Oct;4(10):2425-32. Clin Cancer Res. 1998. PMID: 9796974

10

[Combination therapy of 5-FU and low dose CDDP for advanced and recurrence gastric cancer].

Chung YS, Yamashita Y, Nakata B, Nitta A, Inoue T, Hirayama K, Ogawa M, Kubo T, Kato Y, Shirasaka T, et al. Chung YS, et al. Among authors: ogawa m. Gan To Kagaku Ryoho. 1995 Jan;22(1):149-51. Gan To Kagaku Ryoho. 1995. PMID: 7826072 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,818 results

Search Page

Filters